n-acetylneuraminic acid has been researched along with benzyl-alpha-n-acetylgalactosamine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jalkanen, S; Salmi, M | 1 |
| Atwood, WJ; Liu, CK; Wei, G | 1 |
| Barbat, A; Carrière, V; de Bolos, C; Delannoy, P; Hennebicq-Reig, S; Huet, G; Kim, I; Lesuffleur, T; Real, FX; Ulloa, F; Zweibaum, A | 1 |
| Kelm, S; Schauer, R; Strenge, K | 1 |
| Franci, C; Real, FX; Ulloa, F | 1 |
| Lenoir, C; Maurice, M; Sapin, C; Slimane, TA; Trugnan, G | 1 |
| Real, FX; Ulloa, F | 2 |
| Hartley, CA; Huang, JA; Stevenson, RA; Studdert, MJ | 1 |
| Campbell, RB; Kalra, AV | 1 |
10 other study(ies) available for n-acetylneuraminic acid and benzyl-alpha-n-acetylgalactosamine
| Article | Year |
|---|---|
Different forms of human vascular adhesion protein-1 (VAP-1) in blood vessels in vivo and in cultured endothelial cells: implications for lymphocyte-endothelial cell adhesion models.
Topics: Acetylgalactosamine; Amidohydrolases; Amine Oxidase (Copper-Containing); Benzyl Compounds; Cell Adhesion; Cell Adhesion Molecules; Cells, Cultured; Cytokines; Cytoplasmic Granules; Cytosol; Endothelium, Vascular; Gene Expression Regulation; Glycosylation; Hexosaminidases; Humans; Lymph Nodes; Molecular Weight; N-Acetylneuraminic Acid; Neuraminidase; Palatine Tonsil; Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase; Protein Processing, Post-Translational; Sialic Acids; Tunicamycin; Umbilical Veins; Venules | 1995 |
Infection of glial cells by the human polyomavirus JC is mediated by an N-linked glycoprotein containing terminal alpha(2-6)-linked sialic acids.
Topics: Acetylgalactosamine; Adult; Antiviral Agents; Benzyl Compounds; Cell Line; Glycoproteins; Humans; Lectins; N-Acetylneuraminic Acid; Neuraminidase; Neuroglia; Polyomavirus; Polyomavirus Infections; Receptors, Virus; Tumor Virus Infections; Tunicamycin; Virus Replication | 1998 |
GalNAc-alpha-O-benzyl inhibits NeuAcalpha2-3 glycosylation and blocks the intracellular transport of apical glycoproteins and mucus in differentiated HT-29 cells.
Topics: Acetylgalactosamine; Benzyl Compounds; Biological Transport; Cell Differentiation; Dose-Response Relationship, Drug; Glycoproteins; Glycosylation; Golgi Apparatus; HT29 Cells; Humans; Microvilli; Mucins; Mucus; N-Acetylneuraminic Acid; Neuraminic Acids; Oligosaccharides | 1998 |
Binding partners for the myelin-associated glycoprotein of N2A neuroblastoma cells.
Topics: Acetylgalactosamine; Animals; Benzyl Compounds; Binding Sites; Binding, Competitive; Concanavalin A; Glucosamine; Glycoproteins; Glycosylation; Mice; Molecular Weight; Myelin-Associated Glycoprotein; N-Acetylneuraminic Acid; Neuraminidase; Neuroblastoma; Neurons; Polysaccharides; Protein Binding; Staphylococcal Protein A; Swainsonine; Tumor Cells, Cultured | 1999 |
GalNAc-alpha -O-benzyl inhibits sialylation of de Novo synthesized apical but not basolateral sialoglycoproteins and blocks lysosomal enzyme processing in a post-trans-Golgi network compartment.
Topics: Acetylgalactosamine; alpha-Glucosidases; Benzyl Compounds; Cell Compartmentation; Cell Membrane; Golgi Apparatus; HT29 Cells; Humans; Lysosomes; N-Acetylneuraminic Acid; Protein Processing, Post-Translational; Sialoglycoproteins | 2000 |
Apical secretion and sialylation of soluble dipeptidyl peptidase IV are two related events.
Topics: Acetylgalactosamine; Animals; Benzyl Compounds; Cell Line; Cell Membrane; Dipeptidyl Peptidase 4; Dogs; Glycosylation; Humans; Intestinal Mucosa; Kidney; Mice; N-Acetylneuraminic Acid; Recombinant Proteins; Transfection; Tumor Cells, Cultured; Urothelium | 2000 |
Differential distribution of sialic acid in alpha2,3 and alpha2,6 linkages in the apical membrane of cultured epithelial cells and tissues.
Topics: Acetylgalactosamine; Agglutinins; Benzyl Compounds; Cell Membrane; Cells, Cultured; Epithelial Cells; Epithelium; Humans; Isomerism; Lectins; Microscopy, Fluorescence; N-Acetylneuraminic Acid; Organ Specificity | 2001 |
Benzyl-N-acetyl-alpha-D-galactosaminide induces a storage disease-like phenotype by perturbing the endocytic pathway.
Topics: Acetylgalactosamine; Benzyl Compounds; Cytoplasmic Vesicles; Endocytosis; HT29 Cells; Humans; In Vitro Techniques; Integrin beta1; Lysosomal Storage Diseases; Membrane Glycoproteins; Mucin-1; N-Acetylneuraminic Acid; Phenotype; Protein Transport; Sialic Acid Storage Disease; Transport Vesicles | 2003 |
Sialic acid acts as a receptor for equine rhinitis A virus binding and infection.
Topics: Acetylgalactosamine; Animals; Aphthovirus; Benzyl Compounds; Cats; Cattle; Cells, Cultured; Chlorocebus aethiops; Cricetinae; Endopeptidases; Flow Cytometry; Horses; Lectins; Membrane Fusion; Mice; Mitogens; Morpholines; N-Acetylneuraminic Acid; Periodic Acid; Picornaviridae Infections; Rabbits; Receptors, Virus; Tunicamycin; Vero Cells; Virus Replication | 2004 |
Mucin impedes cytotoxic effect of 5-FU against growth of human pancreatic cancer cells: overcoming cellular barriers for therapeutic gain.
Topics: Acetylgalactosamine; Antimetabolites, Antineoplastic; Benzyl Compounds; Cell Proliferation; Fluorescent Antibody Technique; Fluorouracil; Glioblastoma; Glycosylation; Humans; Microscopy, Fluorescence; Mucin-1; N-Acetylneuraminic Acid; Neuraminidase; Pancreatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured | 2007 |